How Far Is Too Far
How far from a facility capable of blood transfusion and emergency surgery can first trimester medication abortion be safely provided?

Principle Investigators: Prof. Wendy Norman, Dr. Bonnie Henry, Dr. Sarah Munro, Ass.Prof. Laura Schummers
Co-Investigators: Ass.Prof. Brittany Bingham, Dr. Bonnie Henry, Ass.Prof. Abdul-Fatawu Abdulai, Dr. Sarah Munro, Dr. Elizabeth Nethery, Ass.Prof. Stephanie Begun, Ass.Prof. Elizabeth Darling, Ass.Prof. Sheila Dunn, Prof. Ruth Martin-Misener, Ass.Prof. Renée Monchalin, Ass.Prof. Martha Paynter, Prof. Eleni Stroulia, Prof. Danielle Mazza AM, Prof. Sharon Cameron, Dr. John Reynolds-Wright, Prof. Kristina Gemzell-Danielsson, Ass.Prof. Amanda Cleeve, Ass.Prof. Emily Godfrey
Country Leads: Dr. Sarah Munro (Canada), Prof. Danielle Mazza AM (Australia), Dr. John Reynolds-Wright (Scotland), Ass.Prof. Amanda Cleeve (Sweden)
In 2023, the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) released a detailed document containing Abortion Care Guidelines on medical or surgical abortion. While the document suggested that “Clinical judgement should be used to evaluate selective testing of haemoglobin and blood group prior to abortion in women at increased risk of haemorrhage, including but not limited to anaemia or advanced gestation (Good practice point 3)”, there were no clear guidelines on how to determine women that may be at a risk for a haemorrhage post-MA requiring blood transfusion or on the safe distance from blood transfusion-providing facilities for MA recipients. In addition, the RANZCOG Abortion Care Guidelines in their recommendations for future research stated assessing the following question, “Is there a subgroup of women at higher risk of complications who should be recommended to have an ultrasound? For example, previous uterine surgery, greater risk of ectopic pregnancy”.
The aim of this project is to:
- Describe the timing, incidence, urgency and associated patient and clinical characteristics related to post-medical abortion blood transfusion;
- Investigate experiences of abortion care among remote residents and their health care professionals; and
- Triangulate quantitative and qualitative findings to create knowledge synthesis outputs to inform the decisions of clinical practice guideline committees, health care professionals, and patients.

Principle Investigators: Prof. Wendy Norman, Dr. Bonnie Henry, Dr. Sarah Munro, Ass.Prof. Laura Schummers
Co-Investigators: Ass.Prof. Brittany Bingham, Dr. Bonnie Henry, Ass.Prof. Abdul-Fatawu Abdulai, Dr. Sarah Munro, Dr. Elizabeth Nethery, Ass.Prof. Stephanie Begun, Ass.Prof. Elizabeth Darling, Ass.Prof. Sheila Dunn, Prof. Ruth Martin-Misener, Ass.Prof. Renée Monchalin, Ass.Prof. Martha Paynter, Prof. Eleni Stroulia, Prof. Danielle Mazza AM, Prof. Sharon Cameron, Dr. John Reynolds-Wright, Prof. Kristina Gemzell-Danielsson, Ass.Prof. Amanda Cleeve, Ass.Prof. Emily Godfrey
Country Leads: Dr. Sarah Munro (Canada), Prof. Danielle Mazza AM (Australia), Dr. John Reynolds-Wright (Scotland), Ass.Prof. Amanda Cleeve (Sweden)
This project is funded by the Canadian Institutes of Health Research (CIHR)
Subscribe for out latest updates!
Sign up for updates from the world of women’s sexual and reproductive healthcare research.